Journal Browser
Volume | Year
News and Announcements
View All

Exploring Cardiovascular Regenerative Therapy Using Induced Pluripotent Stem Cells

Submission deadline: 31 October 2024
Special Issue Editors
Tadahisa Sugiura
Department of Cardiothoracic & Vascular Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, New York, United States
Interests: Cardiac Surgery; Tissue Engineering; Heart-Lung Transplantation; Mechanical Circulatory Support; Regenerative Medicine
Special Issue Information

Regenerative therapy has recently emerged for treating various diseases, and numerous preclinical and clinical studies using various types of stem cells and tissue engineering have been proven to improve organ functions. For example, induced pluripotent stem cells (iPSC) represent an unlimited source of a variety of cells because of their great differentiation potential. They are, therefore, one of the most promising sources of cells for cardiovascular regenerative therapy.

This Special Issue calls for original articles and reviews to provide readers of Global Translational Medicine with a comprehensive elucidation of cardiovascular regenerative therapy, stem cell therapy, and induced pluripotent stem cells.


regenerative therapy
stem cell therapy
induced pluripotent stem cell
cardiovascular disease
Manuscript Submission Information

Author registration and submission: Submit your paper along with a cover letter, including the special issue title. Your paper will undergo a fair peer review and be published immediately after acceptance and will be available to an international audience.

Published Paper (1 Paper)
Back to top
Global Translational Medicine, Electronic ISSN: 2811-0021 Published by AccScience Publishing